Media & reagents
GMP manufactured products designed for cell and gene therapy to support your transition from discovery through clinical and commercial manufacturing.
As you scale your cell and gene therapies beyond research, products designed to enable clinical and commercial manufacturing are essential to your success.
The Gibco CTS portfolio of cell and gene therapy products are GMP manufactured, safety tested and backed by regulatory documentation to support your transition from discovery through clinical and commercial manufacturing. Through our CTS solutions, we are committed to helping customers streamline therapeutic development, minimize risk, and ease the burden on their quality systems.
Safety testing with accompanying traceability documentation
- Extensive qualification and testing of critical raw materials
- Final product testing (e.g., mycoplasma, endotoxin, sterility)
- Types of traceability documentation: COO, COA, SDS
Dedicated regulatory and quality teams provide product support for customer filings
- Types of specialized documentation include: DMF, RSF, validation, regulatory agency letters
- Products used in over 200 clinical trials and commercialized therapies
- Global CGT regulatory affairs teams with regional expertise
GMP manufactured products designed for CGT manufacturing
- Designed to meet latest guidance for ancillary materials for CGT (USP 1043*, ISO 20399, EP 5.2.12.*)
- Products manufactured under global quality standards (QMS ISO 9001 or 13485)
- 30 years of GMP-compliant manufacturing
Cell therapy instrumentation
Cell therapy instruments, supporting consumables and software products enable CGMP compliant, closed system manufacturing and allow for physical and digital integration.
Viral vector systems
Cost-effective, scalable solutions designed to transition your gene therapy workflow from discovery to commercial manufacturing.
Cell Therapy Systems support
Providing quality for our customers drives everything we do. In addition to our comprehensive CTS portfolio of products, we offer regulatory documentation to support your transition from research through to commercialization. Experienced cell and gene therapy professionals, technical support teams, and highly specialized scientific teams are available to answer your questions, provide detailed product and protocol consultation, as well as customization services.
CTS AAV-MAX Helper Free AAV Production System
The Gibco CTS AAV-MAX Helper Free AAV Production System enables a smooth transition from discovery through manufacturing, offering one optimized, scalable platform with CGMP manufactured reagent options.
Learn more
Gibco CTS NK-Xpander Medium
Gibco CTS NK-Xpander Medium is designed to proliferate a high yield of functional human NK cells to address the needs of translational and clinical cell therapy researchers with or without the use of feeder cells.
Learn more
Gibco CTS DynaCellect Magnetic Separation System
The CTS DynaCellect Magnetic Separation System is a closed, automated isolation, activation, and bead removal system for cell therapy development and manufacturing.
Learn more
Going green: Enabling sustainability in our CTS products
Less waste
When minimizing waste in your lab, every little bit helps. The 1 L Gibco media bottle uses 39% less source material (33% less for the 500 mL bottle and 23% less for the 100 mL bottle) than comparable media bottles on the market today. Using less material requires less petroleum feedstock and generates less greenhouse gas
Responsibly packaged
Packaging must protect the product inside—but that doesn’t have to mean sacrificing sustainability. GlutaMAX-I Media Supplement ships at ambient temperature. By “going ambient” for the GlutaMAX Supplement, we help divert an annual total of nearly 2,000 kg (2,700 ft3) of EPS from landfills and incinerators, and reduce the total carbon footprint by over 100 tons annually.
For Research Use or Manufacturing of Cell, Gene, or Tissue- Based Products. CAUTION: Not intended for direct administration into humans or animals.
* CTS products are designed to meet USP <1043>, ancillary material responsibilities for cell, gene, and tissue-engineered products, under a robust Quality Management System certified to ISO 9001 or 13485. All aspects of USP <1043> are the responsibility of the end user to assess. We are dedicated to supporting our customers clinical translation. For regulatory documentation support please contact us.
Stylesheet for Classic Wide Template adjustments